Distribution of global respiratory therapy market by condition 2016-2017

The data shows the global respiratory therapy market by condition based on the MAT (moving annual total) until the third quarter of 2017 (October 2016 to September 2017). In that year, the global asthma therapy market generated 20.2 billion USD. Asthma is a major cause of morbidity and mortality globally and it is thought to have become more prevalent in the last decades. Fixed combination doses of preventative and symptomatic treatments are used to combat moderate to severe asthma.